Ross Tubo - Vericel Corp Chief Scientific Officer
| VCEL Stock | USD 46.05 0.60 1.32% |
Executive
Dr. Ross Tubo is Chief Scientific Officer of the Company, effective April 1, 2014. Dr. Tubo joined Vericel in April 2014 with more than twenty years of experience in cell therapy, regenerative medicine, and stem cell biology since 2014.
| Age | 54 |
| Tenure | 10 years |
| Address | 64 Sidney Street, Cambridge, MA, United States, 02139 |
| Phone | 617 588 5555 |
| Web | https://vcel.com |
Vericel Corp Management Efficiency
The company has return on total asset (ROA) of (0.0129) % which means that it has lost $0.0129 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0152) %, meaning that it created substantial loss on money invested by shareholders. Vericel Corp's management efficiency ratios could be used to measure how well Vericel Corp manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.0096. The value of Return On Capital Employed is expected to slide to -0.02. At this time, Vericel Corp's Intangible Assets are quite stable compared to the past year. Debt To Assets is expected to rise to 0.26 this year, although the value of Non Currrent Assets Other will most likely fall to about 732.5 K.Management Performance
| Return On Equity | -0.0152 | ||||
| Return On Asset | -0.0129 |
Vericel Corp Ord Leadership Team
Elected by the shareholders, the Vericel Corp's board of directors comprises two types of representatives: Vericel Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vericel. The board's role is to monitor Vericel Corp's management team and ensure that shareholders' interests are well served. Vericel Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vericel Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daniel Orlando, COO | ||
| Alan Rubino, Independent Director | ||
| Gerard Michel, CFO, Vice President - Corporate Development | ||
| Roland DeAngelis, Senior Operations | ||
| Robert Zerbe, Independent Chairman of the Board | ||
| Dominick Colangelo, President CEO, Chief Accounting Officer, Treasurer, Director | ||
| Ross Tubo, Chief Scientific Officer | ||
| Jonathan Hopper, Chief Medical Officer | ||
| Joseph Mara, CFO Treasurer | ||
| Patrick Helfrich, Vice Strategy | ||
| David Recker, Chief Medical Officer | ||
| Howard Leiner, Executive Vice President CTO | ||
| Mike Gilligan, Senior Sales | ||
| Patrick Fowler, Senior Strategy | ||
| Sean Flynn, Chief Officer | ||
| MB FRCSEd, Chief Officer | ||
| Heidi Hagen, Director | ||
| Heidi Hassen, Senior Resources | ||
| Steven Gilman, Director | ||
| Paul Wotton, Director | ||
| Dominick Esq, President CEO | ||
| Jonathan Siegal, VP Officer | ||
| Michael Halpin, Chief Officer | ||
| Eric Burns, Vice Relations | ||
| Kevin McLaughlin, Director |
Vericel Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vericel Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0152 | ||||
| Return On Asset | -0.0129 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 2.2 B | ||||
| Shares Outstanding | 48.38 M | ||||
| Shares Owned By Insiders | 0.84 % | ||||
| Shares Owned By Institutions | 99.16 % | ||||
| Number Of Shares Shorted | 4.53 M | ||||
| Price To Earning | 357.33 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Vericel Corp Ord information on this page should be used as a complementary analysis to other Vericel Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Vericel Stock analysis
When running Vericel Corp's price analysis, check to measure Vericel Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vericel Corp is operating at the current time. Most of Vericel Corp's value examination focuses on studying past and present price action to predict the probability of Vericel Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vericel Corp's price. Additionally, you may evaluate how the addition of Vericel Corp to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is Vericel Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.045 | Earnings Share (0.07) | Revenue Per Share 4.15 | Quarterly Revenue Growth 0.233 | Return On Assets (0.01) |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.